NCT01438359View on ClinicalTrials.gov

A Drug-Drug Interaction Study of Furosemide and PA21

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Healthy
Interventions
DRUG

PA21 and Furosemide with food

The maximum dose of PA21 will be 15.0 g/day. The maximum dose of Furosemide will be 40 mg/day

DRUG

No PA21; Furosemide with food

The maximum dosage of Furosemide will be 40 mg/day

DRUG

PA21 with food and Furosemide 2hrs later

The maximum dose of PA21 will be 15 g/day. The maximum dose of Furosemide will be 40 mg/day

Trial Locations (1)

92801

ACRI - Phase 1, Anaheim

Sponsors

Lead Sponsor

Vifor Pharma
All Listed Sponsors
lead

Vifor Pharma

INDUSTRY